Weight loss injections have been making headlines in the UK, with the Medicines and Healthcare Products Regulatory Agency (MHRA) reporting 82 deaths associated with GLP-1RA drugs like Mounjaro, Wegovy, and Ozempic, as of January 31
Refer to Table 81 for the final OPPS APC and status indicator assignment for HCPCS code G0566 for CY 2026
For patients on weight management formulations (Wegovy, Saxenda, Zepbound), providers should follow FDA label guidance to monitor for suicidal thoughts or behaviors and discontinue medication if these occur
Novel ophthalmic PDT laser platform to target oncology and various other retinal indications
The BCBS Federal Employee Program moved GLP-1s to non-covered formulary tiers
Glutathione for all: Why Sun Protection Matters for Everyone Sun damage is not exclusive to any gender